Reductions seen in median Gastrointestinal Symptom Rating Scale-Irritable Bowel Syndrome score, Patient Assessment of Gastrointestinal Symptom Severity Index

Reduction seen in risk for readmission, wound dehiscence, and hematoma, but no significant differences seen in rates of infection, bleeding

Inferior event-free and overall survival seen for patients with obesity, especially children with ALL and CNS tumors

Inclusion of all mental health measures yields very modest increase in C-index and specificity, with no change in sensitivity

In simulated trial, FDI achieved mean absolute errors of 1.57 and 0.70 years for predicting MCI, AD onset, respectively

Male predominance seen in global GC cases and deaths; highest burden seen in cases and deaths in East Asia

Decrease in mortality, morbidity seen with trametinib for children with RASopathy-associated hypertrophic cardiomyopathy

By India Edwards HealthDay ReporterMONDAY, Jan. 13, 2025 (HealthDay News) — U.S. Food and Drug Administration (FDA) officials have uncovered dozens of violations at a McDonald’s supplier tied to last year’s deadly E.coli outbreak, which sickened over 100 people and led to a massive recall of onions used in the …

Four-month regimen recommended for drug-susceptible TB and six-month regimen recommended for drug-resistant TB

Polypill treatment estimated at $8,560 per QALY gained compared with usual care and had high value in 99 percent of simulations